0	80	insulin	metformin + liraglutide	A1C	xmlns:ns0="http://www.w3.org/1999/xlink">Addition of insulin detemir further reduced A1C compared with continued metformin + liraglutide (−0.51% [n = 162] vs. +0.02% [n = 157], respectively; estimated treatment difference [ETD] −0.52 [95% CI −0.68 to −0.36]; P < 0.0001), resulting in A1C values of 7.1 and 7.5%, respectively, at week 26 (Fig.
